Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2010

Dec 21, 2010

30071_dirs_2010-12-21_3e0ff6b3-266f-442b-acc0-794f1fe0a3b0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-12-17

Reporting Person: PACE GARY W (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-12-17 Resmed Common Stock J 77273 $21.6069 Acquired 77273 Direct

Footnotes

F1: On 8/10/2007 Dr. Pace entered into a Variable Forward Sales contract with CSFB with an initial floor price of $43.2138 (pre-split) and a maturity date of 12/17/2010. This entry represents a settlement of the Variable Forward Sales contract and a return of 77,273 shares from indirect to direct holdings between 12/17/2010 and December 22, 2010.